Literature DB >> 20066438

PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis.

Yoshito Ishizaki1, Naoko Yukaya, Koichi Kusuhara, Ryutaro Kira, Hiroyuki Torisu, Kenji Ihara, Yasunari Sakai, Masafumi Sanefuji, Judy R Pipo-Deveza, Catherine Lynn T Silao, Benilda C Sanchez, Marissa B Lukban, Aida M Salonga, Toshiro Hara.   

Abstract

Although the exact pathogenesis of subacute sclerosing panencephalitis (SSPE) remains to be determined, our previous data suggested a genetic contribution to the host susceptibility to SSPE. During chronic viral infection, virus-specific cytotoxic T lymphocytes display poor effector functions. Since co-inhibitory molecules are involved in the suppression of T lymphocytes, we investigated whether single nucleotide polymorphisms (SNPs) of genes encoding co-inhibitory molecules contributed to a susceptibility to SSPE. Association studies on a total of 20 SNPs in 8 genes (CTLA4, CD80, CD86, PD1, PDL1, PDL2, BTLA and HVEM) and subsequent haplotype analysis of 4 SNPs in the PD1 genes were performed in Japanese and Filipino SSPE patients and controls. Then, we investigated a functional difference in promoter activity of two haplotypes and compared the expression levels of PD1 between SSPE and controls. The frequency of GCG(C) haplotype of PD1 containing -606G allele was significantly higher in SSPE patients than in controls both in Japanese and in Filipinos. The promoter activity was significantly higher in the construct with -606G allele than in that with -606A allele. The expression levels of PD1 were significantly higher in SSPE patients than in the controls. Our results suggested that the PD1 gene contributed to a genetic susceptibility to SSPE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20066438     DOI: 10.1007/s00439-009-0781-z

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  40 in total

1.  Efficiency and power in genetic association studies.

Authors:  Paul I W de Bakker; Roman Yelensky; Itsik Pe'er; Stacey B Gabriel; Mark J Daly; David Altshuler
Journal:  Nat Genet       Date:  2005-10-23       Impact factor: 38.330

2.  T-cell tolerance or function is determined by combinatorial costimulatory signals.

Authors:  Roza Nurieva; Sunil Thomas; Thang Nguyen; Natalia Martin-Orozco; Ying Wang; Murali-Krishna Kaja; Xue-Zhong Yu; Chen Dong
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

3.  SSPE in the developing world.

Authors: 
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

Review 4.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Authors:  Arlene H Sharpe; E John Wherry; Rafi Ahmed; Gordon J Freeman
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

5.  Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability.

Authors:  T Nakayama; T Mori; S Yamaguchi; S Sonoda; S Asamura; R Yamashita; Y Takeuchi; T Urano
Journal:  Virus Res       Date:  1995-01       Impact factor: 3.303

6.  Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection.

Authors:  Leland J Yee; Kevin A Perez; Jianming Tang; Dirk J van Leeuwen; Richard A Kaslow
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

7.  Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes.

Authors:  C Nielsen; D Hansen; S Husby; B B Jacobsen; S T Lillevang
Journal:  Tissue Antigens       Date:  2003-12

8.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

9.  PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.

Authors:  Constantinos Petrovas; Joseph P Casazza; Jason M Brenchley; David A Price; Emma Gostick; William C Adams; Melissa L Precopio; Timothy Schacker; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

10.  PD-1 inhibits antiviral immunity at the effector phase in the liver.

Authors:  Yoshiko Iwai; Seigo Terawaki; Masaya Ikegawa; Taku Okazaki; Tasuku Honjo
Journal:  J Exp Med       Date:  2003-07-07       Impact factor: 14.307

View more
  12 in total

1.  Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma.

Authors:  Farshid Fathi; Batool Zamani; Ahmad Piroozmand; Samaneh Mozafarpoor; Effat Seyedhashemi; Reza ArefNezhad; Hossein Motedayyen
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

2.  PD-1 gene promoter polymorphisms correlate with a poor prognosis in non-small cell lung cancer.

Authors:  Hidefumi Sasaki; Tsutomu Tatemaysu; Katsuhiro Okuda; Satoru Moriyama; Motoki Yano; Yoshitaka Fujii
Journal:  Mol Clin Oncol       Date:  2014-07-24

Review 3.  T cell costimulation and coinhibition: genetics and disease.

Authors:  Lisa Scandiuzzi; Kaya Ghosh; Xingxing Zang
Journal:  Discov Med       Date:  2011-08       Impact factor: 2.970

4.  PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma.

Authors:  Tetsuhiro Kasamatsu; Maaya Awata; Rei Ishihara; Yuki Murakami; Nanami Gotoh; Morio Matsumoto; Morio Sawamura; Akihiko Yokohama; Hiroshi Handa; Norifumi Tsukamoto; Takayuki Saitoh; Hirokazu Murakami
Journal:  Clin Exp Med       Date:  2019-10-16       Impact factor: 3.984

Review 5.  Coinhibitory molecules in autoimmune diseases.

Authors:  Norihiko Watanabe; Hiroshi Nakajima
Journal:  Clin Dev Immunol       Date:  2012-09-11

6.  A versatile system for rapid multiplex genome-edited CAR T cell generation.

Authors:  Jiangtao Ren; Xuhua Zhang; Xiaojun Liu; Chongyun Fang; Shuguang Jiang; Carl H June; Yangbing Zhao
Journal:  Oncotarget       Date:  2017-03-07

Review 7.  Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.

Authors:  Marta Wagner; Monika Jasek; Lidia Karabon
Journal:  Front Immunol       Date:  2021-01-14       Impact factor: 7.561

8.  Association of genetic variants of PD1 with recurrent pregnancy loss.

Authors:  Yuko Hayashi; Takeshi Nishiyama; Masahiro Nakatochi; Shugo Suzuki; Satoru Takahashi; Mayumi Sugiura-Ogasawara
Journal:  Reprod Med Biol       Date:  2018-03-23

Review 9.  Subacute sclerosing panencephalitis in pregnancy.

Authors:  Michael H Chiu; Bonnie Meatherall; Ana Nikolic; Kristine Cannon; Kevin Fonseca; Jeffrey T Joseph; Judy MacDonald; Kanti Pabbaraju; Raymond Tellier; Sallene Wong; Marcus W Koch
Journal:  Lancet Infect Dis       Date:  2016-01-20       Impact factor: 25.071

10.  Increased PD-1 Level in Severe Cervical Injury Is Associated With the Rare Programmed Cell Death 1 (PDCD1) rs36084323 A Allele in a Dominant Model.

Authors:  Mauro César da Silva; Fernanda Silva Medeiros; Neila Caroline Henrique da Silva; Larissa Albuquerque Paiva; Fabiana Oliveira Dos Santos Gomes; Matheus Costa E Silva; Thailany Thays Gomes; Christina Alves Peixoto; Maria Carolina Valença Rygaard; Maria Luiza Bezerra Menezes; Stefan Welkovic; Eduardo Antônio Donadi; Norma Lucena-Silva
Journal:  Front Cell Infect Microbiol       Date:  2021-07-01       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.